Single-dose rituximab for remission induction and maintenance therapy in ANCA-associated vasculitis: a retrospective analysis of 17 patients

• Published in: Scandinavian journal of rheumatology Vol. 43; no. 6; pp. 519 - 523
• Main Authors: Moog, P, Probst, M, Kuechle, C, Hauser, C, Heemann, U, Thuermel, K
• Format: Journal Article
• Language: English
• Published: England Informa Healthcare 01.11.2014; Taylor & Francis
• Subjects: Adult; Aged; Aged, 80 and over; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy; Antibodies, Monoclonal, Murine-Derived - adverse effects; Antibodies, Monoclonal, Murine-Derived - therapeutic use; Female; Humans; Male; Middle Aged; Remission Induction; Retrospective Studies; Rituximab

Objectives: The aim of this study was to evaluate the efficacy of a repeated single-dose rituximab (RTX) regimen for remission induction and maintenance in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). Method: We performed a retrospective analysis of all patients with an e...